Pattern of colistin resistance in Klebsiella isolates in an Intensive Care Unit of a tertiary care hospital in India

• Main Authors: Kanwalpreet Sodhi, Vishal Mittal, Muktanjali Arya, Manender Kumar, Atul Phillips, Benika Kajla
• Format: Article
• Language: English
• Published: Elsevier 2020-07-01
• Series: Journal of Infection and Public Health
• Subjects: Multidrug resistant (MDR) organisms; Colistin resistance; Colistin resistant Klebsiella species; Antimicrobial resistance; Antibiotic surveillance
• Online Access: http://www.sciencedirect.com/science/article/pii/S1876034119303624

Background: Carbapenem resistance among multidrug resistant organism is a growing global concern with high rates being reported from South Asia and Mediterranean countries. It is associated not only with high morbidity and mortality, but also pose a grave health hazard. Among various studies, it has been found that among the gram-negative bacteria Klebsiella species is found to have a high resistance. The aim of the study was to evaluate the prevalence and pattern of colistin resistance in Klebsiella species (spp.) in a tertiary care hospital in India. Methods: An audit of microbiological data of all Klebsiella spp. isolates from blood, urine, sputum and pus was collected from patients admitted to intensive care unit (ICUs) between 1st January 2015 to 31st December 2017 and the prevalence of Colistin resistance in Klebsiella spp. was calculated. Results: Over a period of thirty six months, 2499 isolates were identified from culture positive specimen of blood, urine, sputum, broncho-alveolar lavage (BAL) fluid and pus from patients admitted to ICU. Among the total isolates 21.32% (n = 533) of Klebsiella spp. were isolated and 1.28% (n = 30) of isolates were colistin resistant. In patients admitted to ICU, colistin resistant Klebsiella spp. was identified in 8.75% (n = 14) of the total blood samples, 4.26% (n = 7) in urine samples and 4.4% (n = 8) in sputum and BAL samples. Conclusion: The prevalence of Colistin resistant Klebsiella spp. was estimated to be 5.6% in our ICU. Colistin resistant Klebsiella is becoming an emerging threat in ICU settings limiting further treatment options. Stringent surveillance and robust antibiotic stewardship program to tide over this crisis is need of the hour.